DexCom (DXCM) Insider Trading & Ownership

0.28% of DexCom stock is owned by insiders. Learn more on DXCM's insider holdings.

The following insider purchased DXCM shares in the last 24 months: Jacob Steven Leach ($1,001,728.00).

Insiders have purchased a total of 18,200 DXCM shares in the last 24 months for a total of $1,001,728.00 bought.

The following insiders have sold DXCM shares in the last 24 months: Bridgette P Heller ($257,803.12), Jacob Steven Leach ($1,271,175.72), Jereme M Sylvain ($784,164.15), Kevin R Sayer ($5,186,439.93), Kyle Malady ($53,933.62), Mark G Foletta ($451,522.50), Michael Jon Brown ($2,356,953.19), Nicholas Augustinos ($517,906.02), Richard Alexander Collins ($389,410.46), and Sadie Stern ($1,295,616.86).

Insiders have sold a total of 162,592 DexCom shares in the last 24 months for a total of $12,564,925.57 sold.

Ro Khanna (D-CA), John Boozman (R-AR), and Michael T. McCaul (R-TX) have bought shares of DexCom in the last year totaling $104,500. Tina Smith (D-MN), Ro Khanna (D-CA), and Michael T. McCaul (R-TX) have sold shares totaling $578,500.